75 related articles for article (PubMed ID: 15814196)
1. Protection by dietary zinc in ALS mutant G93A SOD transgenic mice.
Ermilova IP; Ermilov VB; Levy M; Ho E; Pereira C; Beckman JS
Neurosci Lett; 2005 Apr; 379(1):42-6. PubMed ID: 15814196
[TBL] [Abstract][Full Text] [Related]
2. Lack of involvement of neuronal nitric oxide synthase in the pathogenesis of a transgenic mouse model of familial amyotrophic lateral sclerosis.
Facchinetti F; Sasaki M; Cutting FB; Zhai P; MacDonald JE; Reif D; Beal MF; Huang PL; Dawson TM; Gurney ME; Dawson VL
Neuroscience; 1999; 90(4):1483-92. PubMed ID: 10338314
[TBL] [Abstract][Full Text] [Related]
3. Zinc amplifies mSOD1-mediated toxicity in a transgenic mouse model of amyotrophic lateral sclerosis.
Groeneveld GJ; de Leeuw van Weenen J; van Muiswinkel FL; Veldman H; Veldink JH; Wokke JH; Bär PR; van den Berg LH
Neurosci Lett; 2003 Dec; 352(3):175-8. PubMed ID: 14625013
[TBL] [Abstract][Full Text] [Related]
4. Absence of p53: no effect in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Kuntz C; Kinoshita Y; Beal MF; Donehower LA; Morrison RS
Exp Neurol; 2000 Sep; 165(1):184-90. PubMed ID: 10964497
[TBL] [Abstract][Full Text] [Related]
5. Cu,Zn-superoxide dismutase increases toxicity of mutant and zinc-deficient superoxide dismutase by enhancing protein stability.
Garner MA; Ricart KC; Roberts BR; Bomben VC; Basso M; Ye Y; Sahawneh J; Franco MC; Beckman JS; Estévez AG
J Biol Chem; 2010 Oct; 285(44):33885-97. PubMed ID: 20663894
[TBL] [Abstract][Full Text] [Related]
6. Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis.
Andreassen OA; Ferrante RJ; Klivenyi P; Klein AM; Shinobu LA; Epstein CJ; Beal MF
Ann Neurol; 2000 Apr; 47(4):447-55. PubMed ID: 10762155
[TBL] [Abstract][Full Text] [Related]
7. MnSOD deficiency has a differential effect on disease progression in two different ALS mutant mouse models.
Muller FL; Liu Y; Jernigan A; Borchelt D; Richardson A; Van Remmen H
Muscle Nerve; 2008 Sep; 38(3):1173-83. PubMed ID: 18720509
[TBL] [Abstract][Full Text] [Related]
8. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
Cervetto C; Frattaroli D; Maura G; Marcoli M
Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
[TBL] [Abstract][Full Text] [Related]
9. Transient caloric restriction in early adulthood hastens disease endpoint in male, but not female, Cu/Zn-SOD mutant G93A mice.
Hamadeh MJ; Tarnopolsky MA
Muscle Nerve; 2006 Dec; 34(6):709-19. PubMed ID: 16941656
[TBL] [Abstract][Full Text] [Related]
10. Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death.
Martin LJ; Liu Z; Chen K; Price AC; Pan Y; Swaby JA; Golden WC
J Comp Neurol; 2007 Jan; 500(1):20-46. PubMed ID: 17099894
[TBL] [Abstract][Full Text] [Related]
11. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
[TBL] [Abstract][Full Text] [Related]
12. Metallothionein proteins expression, copper and zinc concentrations, and lipid peroxidation level in a rodent model for amyotrophic lateral sclerosis.
Tokuda E; Ono S; Ishige K; Naganuma A; Ito Y; Suzuki T
Toxicology; 2007 Jan; 229(1-2):33-41. PubMed ID: 17097207
[TBL] [Abstract][Full Text] [Related]
13. Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite.
Crow JP; Sampson JB; Zhuang Y; Thompson JA; Beckman JS
J Neurochem; 1997 Nov; 69(5):1936-44. PubMed ID: 9349538
[TBL] [Abstract][Full Text] [Related]
14. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.
Haenggeli C; Julien JP; Mosley RL; Perez N; Dhar A; Gendelman HE; Rothstein JD
Neurobiol Dis; 2007 Apr; 26(1):146-52. PubMed ID: 17276077
[TBL] [Abstract][Full Text] [Related]
16. Metallothionein expression is altered in a transgenic murine model of familial amyotrophic lateral sclerosis.
Gong YH; Elliott JL
Exp Neurol; 2000 Mar; 162(1):27-36. PubMed ID: 10716886
[TBL] [Abstract][Full Text] [Related]
17. Dynamic properties of the G93A mutant of copper-zinc superoxide dismutase as detected by NMR spectroscopy: implications for the pathology of familial amyotrophic lateral sclerosis.
Shipp EL; Cantini F; Bertini I; Valentine JS; Banci L
Biochemistry; 2003 Feb; 42(7):1890-9. PubMed ID: 12590575
[TBL] [Abstract][Full Text] [Related]
18. Focal dysfunction of the proteasome: a pathogenic factor in a mouse model of amyotrophic lateral sclerosis.
Kabashi E; Agar JN; Taylor DM; Minotti S; Durham HD
J Neurochem; 2004 Jun; 89(6):1325-35. PubMed ID: 15189335
[TBL] [Abstract][Full Text] [Related]
19. Dietary vitamin D3 supplementation at 10× the adequate intake improves functional capacity in the G93A transgenic mouse model of ALS, a pilot study.
Gianforcaro A; Hamadeh MJ
CNS Neurosci Ther; 2012 Jul; 18(7):547-57. PubMed ID: 22591278
[TBL] [Abstract][Full Text] [Related]
20. The lack of effect of specific overexpression of IGF-1 in the central nervous system or skeletal muscle on pathophysiology in the G93A SOD-1 mouse model of ALS.
Messi ML; Clark HM; Prevette DM; Oppenheim RW; Delbono O
Exp Neurol; 2007 Sep; 207(1):52-63. PubMed ID: 17597610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
